AI assistant
Sending…
ESSA Pharma Inc. — Director's Dealing 2020
Oct 2, 2020
35249_dirs_2020-10-01_8583d6d7-b618-4ba5-a84b-9e241d82a929.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ESSA Pharma Inc. (EPIX)
CIK: 0001633932
Period of Report: 2020-10-01
Reporting Person: Thorell Marella (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 2881 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options | $3.23 | 2029-10-04 | Common Shares (25000) | Direct | |
| Options | $4.67 | 2029-10-30 | Common Shares (25000) | Direct |
More from ESSA Pharma Inc.
Regulatory Filings
2025
Nov 17
Major Shareholding Notification
2025
Nov 14
Major Shareholding Notification
2025
Nov 14
Regulatory Filings
2025
Oct 28
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15
Director's Dealing
2025
Oct 15